Pompano Beach, Fla., July 14, 2014 (GLOBE NEWSWIRE) -- DS Healthcare Group, Inc. (NASDAQ: DSKX), a leading developer of personal care products and specialty pharmaceuticals, announced today that the first DS Laboratories store worldwide has opened in Shanghai, China in partnership with the Company's Chinese distributor. The store exclusively features a complete line of DS Healthcare products including the Company's clinically proven, industry-leading Spectral line of hair loss treatments and Revita hair stimulating shampoos and conditioners. The Company plans to open additional partnership stores worldwide in the coming months.
According to Euromonitor International, total sales of beauty and personal care products in China tripled in size from 2000 to reach an estimated $24 billion in 2010. Euromonitor projects the market will grow to $34 billion by 2015. Analysts credit China's fast growing middle class for the rapid growth in sales.
"As we build the premier global brand in clinically proven personal care and Rx products, this retail store in Shanghai is an important component of our country-wide distribution and brand building strategy in China. We entered into a distribution agreement with our Chinese partner in September and it's quickly become a very productive working relationship, as evidenced by the launch of this first DS Laboratories retail boutique. We are excited about the growth potential in this very important global market," stated DS Healthcare President and CEO Daniel Khesin.
About DS Healthcare Group
DS Healthcare Group Inc. leads in the development of biotechnology for topical therapies. It markets through online and specialty retailers, distributors, cosmetics wholesalers, and salons. Its research has led to a highly innovative portfolio of personal care products and additional innovations in pharmaceutical projects. For more information on DS Healthcare Group's flagship brand, visit www.dslaboratories.com
Except for statements of historical fact, the matters discussed in this press release are forward-looking and made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies, and are generally preceded by words such as "future," "plan" or "planned," "expects," or "projected." These forward-looking statements reflect numerous assumptions and involve a variety of risks and uncertainties, many of which are beyond the company's control that may cause actual results to differ materially from stated expectations. These risk factors include, among others, limited operating history, difficulty in developing and marketing products, intense competition, and additional risks factors as discussed in reports filed by the company with the Securities and Exchange Commission, which are available at http://www.sec.gov.
CONTACT: Laurel Moody Corporate Profile 1.646.810.0608
Source:DS Healthcare Group,Inc.